Date: 2013-01-08
Type of information: Company acquisition
Acquired company: Aureus Sciences (France)
Acquiring company: Elsevier (The Netherlands)
Amount: undisclosed
Terms: Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced the acquisition of Aureus Sciences, a Paris, France based privately held company that provides databases and information tools to pharmaceutical and biotech companies.
The acquisition is effective immediately and financial terms of the transaction are not being disclosed.
Details: Formed in 2002, Aureus Sciences gathers quantitative biological activity data for major therapeutic drug targets. This content enables researchers to identify the most promising compounds, repurpose existing compounds and identify targets with which the new compounds might interact. The company provides scientific databases and software applications for researchers involved in the drug discovery and development process. Furthermore, the company focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process.
The acquisition enables the combination of high quality and deeply extracted content from both companies to launch new solutions for pharmaceutical and biotech customers. The first evidence of this will be seen early this year with the release of a new medicinal chemistry solution.
Related: Databases
Drug discovery
R&D
